Figure 1. Global Regenerative Medicine (Bone and Joint) Market Value (US$ Mn), 2016-2027
Global regenerative medicine (Bone and Joint) market size is estimated to be valued at US$ 7,090.1million in 2020 and is expected to exhibit a CAGR of 10.3% over the forecast period (2020-2027).
Regulatory authorities and government organizations are engaged in launching various programs, in order to boost growth of the global regenerative medicine (bone and joint) market. For instance, in January 2017, the U.S. Food and Drug Administration (FDA) launched a new designation program for regenerative medicine therapies. This ‘Regenerative Medicine Therapy (RMAT) Designation’ program will foster the approval and development of regenerative medicine products.
Regenerative Medicine (Bone and Joint) Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients